Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
The price of Unitedhealth Group Inc (NYSE: UNH) closed at $303.88 in the last session, up 1.15% from day before closing price of $300.43. In other words, the price has increased by $1.15 from its previous closing price. On the day, 9.89 million shares were traded. UNH stock price reached its highest trading level at $305.97 during the session, while it also had its lowest trading level at $300.5.
Ratios:
We take a closer look at UNH’s different ratios to gain a better understanding of the stock. In the meantime, Its Debt-to-Equity ratio is 0.84 whereas as Long-Term Debt/Eq ratio is at 0.78.
Robert W. Baird Downgraded its Outperform to Neutral on June 11, 2025, while the target price for the stock was maintained at $312.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jun 10 ’25 when Conway Patrick Hugh sold 589 shares for $305.00 per share. The transaction valued at 179,645 led to the insider holds 10,398 shares of the business.
Conway Patrick Hugh bought 589 shares of UNH for $179,645 on Jun 10 ’25. On May 16 ’25, another insider, REX JOHN F, who serves as the President & CFO of the company, bought 17,175 shares for $291.12 each. As a result, the insider paid 4,999,919 and bolstered with 203,796 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, UNH now has a Market Capitalization of 275216203776 and an Enterprise Value of 332449087488. As of this moment, Unitedhealth’s Price-to-Earnings (P/E) ratio for their current fiscal year is 13.16, and their Forward P/E ratio for the next fiscal year is 16.74. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.65 while its Price-to-Book (P/B) ratio in mrq is 2.90. Its current Enterprise Value per Revenue stands at 0.786 whereas that against EBITDA is 9.901.
Stock Price History:
The Beta on a monthly basis for UNH is 0.45, which has changed by -0.48631608 over the last 52 weeks, in comparison to a change of 0.1590569 over the same period for the S&P500. Over the past 52 weeks, UNH has reached a high of $630.73, while it has fallen to a 52-week low of $234.60. The 50-Day Moving Average of the stock is 5.45%, while the 200-Day Moving Average is calculated to be -30.01%.
Shares Statistics:
According to the various share statistics, UNH traded on average about 16.47M shares per day over the past 3-months and 23531140 shares per day over the past 10 days. A total of 905.00M shares are outstanding, with a floating share count of 903.33M. Insiders hold about 0.26% of the company’s shares, while institutions hold 86.77% stake in the company. Shares short for UNH as of 1755216000 were 16603605 with a Short Ratio of 1.01, compared to 1752537600 on 12707260. Therefore, it implies a Short% of Shares Outstanding of 16603605 and a Short% of Float of 1.8399999999999999.
Dividends & Splits
The forward annual dividend rate for UNH is 8.51, which was 8.51 in the trailing 12 months. Against a Trailing Annual Dividend Yield of 0.028326068The stock’s 5-year Average Dividend Yield is 1.43. The current Payout Ratio is 52.75% for UNH, which recently paid a dividend on 2025-06-16 with an ex-dividend date of 2025-09-15. Stock splits for the company last occurred on 2005-05-31 when the company split stock in a 2:1 ratio.
Earnings Estimates
The dynamic stock of Unitedhealth Group Inc (UNH) is currently attracting attention from 18.0 analysts actively involved in rating its market status.The consensus estimate for the next quarter is $2.1, with high estimates of $2.86 and low estimates of $1.57.
Analysts are recommending an EPS of between $16.82 and $16.0 for the fiscal current year, implying an average EPS of $16.22. EPS for the following year is $18.89, with 26.0 analysts recommending between $30.43 and $16.48.
Revenue Estimates
According to 18 analysts, the current quarter’s revenue is expected to be $113.22B. It ranges from a high estimate of $114.65B to a low estimate of $110.16B. As of the current estimate, Unitedhealth Group Inc’s year-ago sales were $100.82BFor the next quarter, 18 analysts are estimating revenue of $114.03B. There is a high estimate of $116.38B for the next quarter, whereas the lowest estimate is $110.6B.
A total of 22 analysts have provided revenue estimates for UNH’s current fiscal year. The highest revenue estimate was $451.16B, while the lowest revenue estimate was $441.94B, resulting in an average revenue estimate of $448.35B. In the same quarter a year ago, actual revenue was $400.28BBased on 22 analysts’ estimates, the company’s revenue will be $468.65B in the next fiscal year. The high estimate is $487.24B and the low estimate is $440.27B.
